Beiqi Biochemical Reprogramming Kit

BeiCell™ （Beiqi Biology）Human chemical reprogramming induced pluripotent stem cell assay kit

--New breakthrough achievements by Professor Deng Hongkui's team at Peking University

Beiqi Biochemical Reprogramming Induction Multi Potential Stem Cell KitBased on the breakthrough achievement of Professor Deng Hongkui's team at Peking University, which utilizes chemical small molecules to induce the transformation of human adult cells into pluripotent stem cells (Nature, 2022; Cell Stem Cell, 2023), it can be developed stably and efficientlyReprogramming human adipose derived stromal cells (ADSCs) and skin fibroblasts (Fibroblast) into chemically induced pluripotent stem cells(Human chemically induced pluripotent stem cells, abbreviated as "human CiPS cells").

Chemical reprogramming is a new generation of human pluripotent stem cell preparation technology independently developed by Professor Deng Hongkui's team at Peking University. Compared with traditional "somatic cell nuclear transfer" and "transgenic overexpression transcription factor" reprogramming to prepare pluripotent stem cells, chemical reprogramming is simpler, more efficient, and safer, solving the "bottleneck" problem in the underlying technology for the development of stem cells and regenerative medicine in China. At present, this cutting-edge technology is authorized and transformed by Beijing Beiqi Biopharmaceutical Co., Ltd. In addition to the preparation kit for chemically reprogramming induced human pluripotent stem cells (CiPSC), the company has also successfully developed research and clinical GMP grade seed cells, and has officially begun commercial cooperation with external parties, such as applications in in in vitro drug screening, organoid differentiation, and clinical drug pipeline development.